Fenofibrate and Energy increased - a phase IV clinical study of FDA data

Summary:

Energy increased is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are female, 60+ old, also take Humira, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Energy increased when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Energy increased?

Energy increased is found to be associated with 541 drugs and 686 conditions by eHealthMe. Check the latest studies of Energy increased.

On Jul, 04, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 12 people (0.03%) have Energy increased.

Could Fenofibrate cause Energy increased?

Among these 12 people:

What is the gender of people who have Energy increased when taking Fenofibrate? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Energy increased when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

What are other side effects people have besides Energy increased? *

Wound Secretion: 5 people, 41.67%
Abdominal Distension: 5 people, 41.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 41.67%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 5 people, 41.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 41.67%
Sleep Disorder: 5 people, 41.67%
Seroma (a tumour like collection of serum in the tissues): 5 people, 41.67%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 5 people, 41.67%
Wound: 5 people, 41.67%
Nervousness: 5 people, 41.67%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 41.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 41.67%
Rashes (redness): 5 people, 41.67%
High Blood Pressure: 5 people, 41.67%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 41.67%
Hypersensitivity: 4 people, 33.33%
Diarrhea: 4 people, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 33.33%
Abnormal Faeces (abnormal stool): 3 people, 25.00%
Anaemia (lack of blood): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Energy increased?

- Check whether Energy increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,456 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Energy increased:

Energy increased (541 drugs)

Browse all the conditions that are associated with Energy increased:

Energy increased (686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.